Application of multi-tumor marker protein chip in the diagnosis of ovarian cancer

LIU Yu,LIN Ding,ZHOU Qi,WANG Dong

DOI: https://doi.org/10.3969/j.issn.1009-0460.2007.03.010

2007-01-01

Chinese Clinical Oncology

Abstract:Objective:To investigate the application of multi-tumor marker protein chip in the diagnosis of ovarian cancer. Methods:The serum levels of 12 tumor markers including CA125,CA19-9,CA153,CA242,CEA, AFP, β-HCG, NSE, PSA, f-PSA, ferritin and HGH were determined by using multi-tumor marker protein chip in 66 patients with malignant ovarian cancer,64 patients with benign gynecologic diseases and 144 healthy women,and its diagnostic value was evaluated. Results:The levels of CA19-9, CEA, CA242, ferritin, AFP, CA125 and CA153 in patients with ovarian cancer were significantly higher than those in patients with benign diseases and healthy controls (P<0.01). The positive rates of CA125, ferritin, CA19-9, CEA, CA242, CA153 were 68.2%, 31.8%, 30.3%, 22.7%, 19.7% and 19.7% in patients with ovarian cancer, respectively, which were significantly higher than those in benign diseases and healthy controls (P<0.001). The protein chip had significantly higher positive rate than any single item of the 12 tumor markers (P<0.001). The diagnostic sensitivity and accuracy of the combined detection of CA125+CA19-9 and CA125+CA19-9+CEA were much higher than those of single CA125 for ovarian cancer. The sensitivity, specificity, accuracy, positive and negative predictive values by protein chip detection were 87.9%, 93.3%, 92.0%, 80.6% and 96.0%,respectively. As compared with CA125 alone, the diagnostic sensitivity and accuracy of the protein chip increased from 68.2% and 90.5% to 87.9% and 92.0%, respectively. Conclusion:The combined detection of tumor markers by protein chip technique is helpful in improving the diagnostic sensitivity and accuracy and valuable for the diagnosis of ovarian cancer.